A Review on Newer Tyrosine Kinase Inhibitors and their Uses

Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 8

Abstract

ABSTRACT Tyrosine Kinase Inhibitors (TKI) can reversibly or irreversibly block the signaling pathway occurring in the extracellular part of the receptor by inhibiting Tyrosine Kinase (TK) phosphorylation. This review included the drugs that were newly marketed or drugs with newer approved uses after 2015, such as Gefitinib, Osimertinib, Crizotinib, Alectinib, Ibrutinib, Cabozantinib. Brigatinib and Lorlatinib are investigational drugs that have not been approved and have shown promising results in trials for the treatment of Anaplastic Lymphoma Kinase (ALK) positive metastatic Non Small Cell Lung Carcinoma (NSCLC). Gefitinib, Osimertinib, Crizotinib, Alectinib were approved for treating NSCLC. Cabozantinib and Lenvatinib were approved for treating renal cell carcinoma and thyroid carcinoma. Ibrutinib was approved for treatment of Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Waldenström macroglobulinemia, previously treated Mantle cell lymphoma and relapsed or refractory Marginal zone lymphoma. TKI have promising efficacy in treating a wide range of oncologic diseases. Hand-foot-skin reaction are the most common side effect of drugs in this category, however, TKI are found to have relatively fewer side effects compared to other anti cancer drugs.

Authors and Affiliations

Nithu M Kumar, Meenu Mathew, KN Anila, S Priyanka

Keywords

Related Articles

Recurrent Vaginal Cuff Dehiscence in a Treated Case of Carcinoma Cervix

Vaginal Cuff Dehiscence (VCD) is partial or total separation of anterior and posterior vaginal cuff layers. We report a case of recurrent vault cuff dehiscence in a patient of cervical carcinoma. A 60-year-old treated ca...

Effectivity of Titanium Oxide Based Nano Particles on E. coli from Clinical Samples

Introduction: Nanoparticles composed of Titanium Oxide (TiO2 ) are non toxic, durable, stable and have a high refractive index with a lot of scope in biomedical applications. Due to their antibacterial effects, they can...

Peritonitis due to Galactomyces geotrichum: A Rare Case Report

ABSTRACT Galactomyces geotrichum is the teleomorphic stage of several unnamed Geotrichum species. They are filamentous yeast like fungi that are ubiquitous in nature. They have been isolated from various sources such as...

Association between Vascular Endothelial Markers and Carotid Intima-Media Thickness in Children and Adolescents with Type 1 Diabetes Mellitus

Introduction: Type 1 Diabetes Mellitus (T1DM) is one of the important risk factor for cardiovascular disease. Endothelial dysfunction and increased Carotid Intima-Media Thickness (CIMT) result in cardiovascular complicat...

Comparison of Normal Resident Flora on the Face of Medical Students who use and who do not use Cosmetics

Introduction: Normal flora of the skin plays a beneficial role in preventing the pathogenic organisms from colonizing the skin and causing infection. It is possible that the facial cosmetics may cause a change in the nor...

Download PDF file
  • EP ID EP529062
  • DOI 10.7860/JCDR/2018/31031.11957
  • Views 54
  • Downloads 0

How To Cite

Nithu M Kumar, Meenu Mathew, KN Anila, S Priyanka (2018). A Review on Newer Tyrosine Kinase Inhibitors and their Uses. Journal of Clinical and Diagnostic Research, 12(8), 1-6. https://europub.co.uk/articles/-A-529062